These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1124 related articles for article (PubMed ID: 32194980)

  • 1. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.
    Zhou Y; Hou Y; Shen J; Huang Y; Martin W; Cheng F
    Cell Discov; 2020; 6():14. PubMed ID: 32194980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAveRUNNER: an R-based tool for drug repurposing.
    Fiscon G; Paci P
    BMC Bioinformatics; 2021 Mar; 22(1):150. PubMed ID: 33757425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.
    Zhou Y; Hou Y; Shen J; Mehra R; Kallianpur A; Culver DA; Gack MU; Farha S; Zein J; Comhair S; Fiocchi C; Stappenbeck T; Chan T; Eng C; Jung JU; Jehi L; Erzurum S; Cheng F
    PLoS Biol; 2020 Nov; 18(11):e3000970. PubMed ID: 33156843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.
    Bogacheva MS; Kuivanen S; Potdar S; Hassinen A; Huuskonen S; Pöhner I; Luck TJ; Turunen L; Feodoroff M; Szirovicza L; Savijoki K; Saarela J; Tammela P; Paavolainen L; Poso A; Varjosalo M; Kallioniemi O; Pietiäinen V; Vapalahti O
    Antiviral Res; 2024 Mar; 223():105813. PubMed ID: 38272320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially repurposable drugs for COVID-19 identified from SARS-CoV-2 Host Protein Interactome.
    Karunakaran KB; Balakrishnan N; Ganapathiraju M
    Res Sq; 2020 May; ():. PubMed ID: 32702734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function.
    Krämer A; Billaud JN; Tugendreich S; Shiffman D; Jones M; Green J
    BMC Bioinformatics; 2021 May; 22(1):229. PubMed ID: 33941085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network-based drug repurposing for HPV-associated cervical cancer.
    Ahmed F; Yang YJ; Samantasinghar A; Kim YW; Ko JB; Choi KH
    Comput Struct Biotechnol J; 2023; 21():5186-5200. PubMed ID: 37920815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets.
    Bellucci G; Ballerini C; Mechelli R; Bigi R; Rinaldi V; Reniè R; Buscarinu MC; Baranzini SE; Madireddy L; Matarese G; Salvetti M; Ristori G
    F1000Res; 2020; 9():992. PubMed ID: 33456761
    [No Abstract]   [Full Text] [Related]  

  • 9. Machine intelligence design of 2019-nCoV drugs.
    Gao K; Nguyen DD; Wang R; Wei GW
    bioRxiv; 2020 Feb; ():. PubMed ID: 32511308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19.
    Zhou Y; Hou Y; Shen J; Kallianpur A; Zein J; Culver DA; Farha S; Comhair S; Fiocchi C; Gack MU; Mehra R; Stappenbeck T; Chan T; Eng C; Jung JU; Jehi L; Erzurum S; Cheng F
    ChemRxiv; 2020 Jul; ():. PubMed ID: 32676577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications.
    Wang Z; Guo K; Gao P; Pu Q; Li C; Hur J; Wu M
    Precis Clin Med; 2021 Dec; 4(4):215-230. PubMed ID: 34993416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning-based integration of network features and chemical structure of compounds for SARS-CoV-2 drug effect analysis.
    Späth J; Wang RS; Humphrey M; Baumbach J; Loscalzo J
    CPT Pharmacometrics Syst Pharmacol; 2024 Feb; 13(2):257-269. PubMed ID: 37950385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach.
    Loganathan T; Ramachandran S; Shankaran P; Nagarajan D; Mohan S S
    PeerJ; 2020; 8():e9357. PubMed ID: 32566414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics.
    Liu DY; Liu JC; Liang S; Meng XH; Greenbaum J; Xiao HM; Tan LJ; Deng HW
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33919660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular targets and system biology approaches for drug repurposing against SARS-CoV-2.
    Singh RK; Yadav BS; Mohapatra TM
    Bull Natl Res Cent; 2020; 44(1):193. PubMed ID: 33230386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis.
    Kumar N; Mishra B; Mehmood A; Athar M; Mukhtar MS
    SSRN; 2020 May; ():3581857. PubMed ID: 32714115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Repurposing for COVID-19 using Graph Neural Network with Genetic, Mechanistic, and Epidemiological Validation.
    Hsieh K; Wang Y; Chen L; Zhao Z; Savitz S; Jiang X; Tang J; Kim Y
    Res Sq; 2020 Dec; ():. PubMed ID: 33330858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies.
    Sardar R; Satish D; Birla S; Gupta D
    Heliyon; 2020 Sep; 6(9):e04658. PubMed ID: 32844125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19.
    Morselli Gysi D; Do Valle Í; Zitnik M; Ameli A; Gan X; Varol O; Ghiassian SD; Patten JJ; Davey R; Loscalzo J; Barabási AL
    ArXiv; 2020 Apr; ():. PubMed ID: 32550253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence.
    Hsieh K; Wang Y; Chen L; Zhao Z; Savitz S; Jiang X; Tang J; Kim Y
    ArXiv; 2022 Feb; ():. PubMed ID: 32995367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.